賦µÀÓªÑø,Enteral nutritionÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
IgGÑÇÀà,IgG subclassesÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Ô˶¯·¢Óý,motor developmentÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
·Î±íÃæ»îÐÔÎïÖÊÏà¹Øµ°°×ÖÊÀà,Pulmonary surfactant-associated proteinsÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¼«µÍ³öÉúÌåÖÊÁ¿,very low birth weightÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÄÉÃ׺ìÉ«ÔªËØÎø,Nano red elemental seleniumÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ºôÎüÖÎÁÆ,respiratory therapyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÖÇÁ¦²âÊÔ,intelligence testÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
p16ink4a»ùÒò,p16ink4a geneÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÉöÑ»·,renal circulationÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
δ½áºÏµ¨ºìËØ,Unconjugated bilirubinÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¸ßƵÕðµ´Í¨Æø,High frequency oscillatory ventilationÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÓÅÏȲßÂÔ,priority strategyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Éñ¾²¡Ñ§¼ì²é,Neurologic examinationÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ȱÑõȱѪÄÔËðÉË,hypoxic-ischemic brain damageÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÁªºÏÕï¶Ï,combined diagnosisÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
±ÈÀý¸¨ÖúÍ¨Æø,Proportional assist ventilationÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÂýÐԷβ¿¼²²¡,chronic lung diseaseÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
³ÖÐø·Î¶¯Âö¸ßѹ,persistent pulmonary hypertensionÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
·Ç½áºÏµ¨ºìËØ,unconjugated bilirubinÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ιËÇ·½·¨,Feeding methodsÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¹ÇÐγɵ°°×4,bone morphogenetic protein 4Ó¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Á£Ï¸°û¼¯Âä´Ì¼¤Òò×Ó(G-CSF),granulocyte colony-stimulating factor(G-CSF)Ó¢Óï¶Ì¾ä,Àý¾ä´óÈ«
³¦µÀÎ¹Ñø,enteral feedingÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
XÏßÌå²ãÉãÓ°Êõ,X-ray computed tomographyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
»Ø¹Ëµ÷²é,Retrospective surveyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÄÔȱÑõȱѪ,Hypoxic ischemic brain damageÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Ôç²úÊó,premature ratÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¹Èë׸ÊëÄS×ªÒÆÃ¸,glutathione S-transferasesÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÖØ×é´Ùºìϸ°ûÉú³ÉËØ,recombinant human erythropoietinÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Àɸñº±×é֯ϸ°ûÔöÉúÖ¢,langerhans cell histiocytosisÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÄÔÊÒÖÜΧ°×ÖÊÈí»¯²¡,periventricular leukomalaciaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¾²Âö±ûÖÖÇòµ°°×,Intravenous immunoglobulinÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¼×»ù±û¶þËá,Methylmalonic acidÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ȱÑõÐÔÐļ¡ËðÉË,ischemic myocardial damageÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Ò©Ãô¼ì²â,Drug sensitivity testÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¾²ÂöÃâÒßÇòµ°°×,intravenous immunoglobulinÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¹¦ÄÜËðº¦,functional impairmentÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
³¦¸ÎÑ»·,enterohepatic circulationÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
É«ËØÊ§½ûÖ¢,Incontinentia pigmentiÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¸ßδ½áºÏµ¨ºìËØÑªÖ¢,unconjugated hyperbilirubinemiaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
³¦Ö×Áö/Õï¶Ï,INTESTINAL NEOPLASMS/diagÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
´¹Ö±¸ÐȾ,vertical transmissionÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÐÂÉúÍÃ,Newborn rabbitÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ѧϰ¡¢¼ÇÒä,learning and memoryÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¸Ð¾õÔ˶¯¹¦ÄÜ,sensorimotor functionÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÀÒËáËó¾úCGMCC0313.1,Clostridium butyricum CGMCC0313.1Ó¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ƽ¹ûÏØ,Pingguo countyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
RHϵͳ,RH systemÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÖÐDZ·üÆÚ·´Ó¦,middle latency responsesÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
·Î±íÃæ»îÐÔµ°°×D,pulmonary surfactant protein DÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Ôç²ú´óÊó,Premature ratsÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
P2X_7ÊÜÌå,P2X_7 ReceptorÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ѪƬ,blood sliceÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÄÔÊÒÖÜΧ-ÄÔÊÒÄÚ³öѪ,Periventricular-intraventricular hemorrhageÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ѪÂú²Ý,Sambucus Adnata WallÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
µ¥ÍÙÒºËáËļºÌÇÉñ¾½ÚÜÕ֬į,monosialotetrahexosyl ganglioside sodiumÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÐÂÉú¶ùȱÑõȱѪÐÔÄÔ²¡(HIE),hypoxic-ischemic encephalopathy(HIE)Ó¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÏÈÌìÐÔ¼××´ÏÙ¹¦ÄܵÍÏÂÖ¢,Congenital hypothyroidismÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÖÓ»ùÒò,Clock geneÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
±ÇËÇÎ¹Ñø,nasal feedingÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
±ÇÈû³ÖÐøÆøµÀÕýÑ¹Í¨Æø,nasal continuous positive airway pressureÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÐÂÉú¶ù·Î͸Ã÷Ĥ²¡,Hyaline membrane diseaseÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÄÔȱѪȱÑõ,cerebral ischemia and hypoxiaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÔçÆÚ´¥Ãþ,neonatal handlingÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÇÐÖµ,cut-off valueÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
͸Ã÷Ĥ²¡,Hyaline membrane diseaseÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÒÅ´«´úл²¡,inherited metabolic diseasesÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÊÓÍøÄ¤ËðÉË,retinal damageÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Í·ÂB³¬,cranial sonographyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
S100BBµ°°×,S100BB proteinÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÆøµÀÕýÑ¹Í¨Æø,Positive airway pressureÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
´«Í³»úÐµÍ¨Æø,conventional mechanical ventilationÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÓлúËáѪ֢,organic acidemiasÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÁÙ´²·Ö¶È,Clinical gradingÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
±ÇÈû³ÖÐøÕýÑ¹Í¨Æø,Nasal continuous positive airway pressureÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Ì¥·àÎüÈë×ÛºÏÖ¢,Meconium aspiration syndromeÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
»»ÑªÊõ,Exchange transfusionÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ðåÕ¶¾3ÐÍ,Herpesvirus 3Ó¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¾Ö²¿Ñõ±¥ºÍ¶È,Regional oxygen saturationÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
G6PDȱÏÝ,G6PD deficiencyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÊԹܷ¨,Tube methodÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÐÂÉú¶ù¸ÎÑ×,Neonatal HepatitisÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ѪÄÔ¼¹ÒºÆÁÕÏ,blood brain barrierÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
NBNAÆÀ·Ö,NBNA scoreÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Ê©½ÝÒò,Monosialo gangliosides-1Ó¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Éú³¤×·¸Ï,catch-up growthÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ABOÈÜѪ²¡,ABO hemolytic diseaseÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Á×ËἡËἤøͬ¹¦Ã¸,creatine phosphokinase MB isozmyeÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÊÒ¹ÜĤϳöѪ,subependymal hemorrhagesÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¼ÆËã»úXÏ߶ϲãɨÃè,X-ray computer tomographyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Æø¹Ü×¢Èë,Intratracheal instillationÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Ó«¹â°ßµã·¨,Fluorescence spot testÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Î¹ÑøÀ§ÄÑ,feeding intoleranceÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Ôç²ú¶ùºôÎüÔÝÍ£,Apnea of prematurityÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÌåÖØÏ½µ,weight lossÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
×ãÔÂÐÂÉú¶ù,Term infantsÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÆêѪµ¨ºìËØ,cord blood bilirubinÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¾Æ¤µ¨ºìËØ,transcutaneous bilirubinÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¹âÕÕÁÆ·¨,light therapyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«

|